(M) Macy’s - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US55616P1049
Stock: Apparel, Accessories, Home Goods, Cosmetics
Total Rating 50
Risk 74
Buy Signal -0.80
| Risk 5d forecast | |
|---|---|
| Volatility | 53.3% |
| Relative Tail Risk | -15.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.89 |
| Alpha | 24.66 |
| Character TTM | |
|---|---|
| Beta | 1.204 |
| Beta Downside | 1.598 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.33% |
| CAGR/Max DD | 0.04 |
EPS (Earnings per Share)
Revenue
Description: M Macy’s March 04, 2026
Macys, Inc. (M) is a US-based omnichannel retailer. It operates department stores, e-commerce platforms, and mobile applications.
The company offers apparel, accessories, cosmetics, and home furnishings across its Macys, Bloomingdales, and Bluemercury brands. This broad product assortment is typical for department stores, which aim to be a one-stop shop for diverse consumer needs.
Macys also has an international presence through licensing agreements in the Middle East.
The company, founded in 1830, was formerly known as Federated Department Stores, Inc. Its business model integrates physical retail with digital channels, a common strategy in the evolving retail sector to reach a wider customer base and enhance shopping convenience.
Further analysis of Macys performance and market position can be found on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 478.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 5.07 > 1.0 |
| NWC/Revenue: 6.59% < 20% (prev 6.30%; Δ 0.29% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.55b > Net Income 478.0m |
| Net Debt (4.80b) to EBITDA (1.62b): 2.96 < 3 |
| Current Ratio: 1.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (274.6m) vs 12m ago -2.45% < -2% |
| Gross Margin: 40.38% > 18% (prev 0.41%; Δ 3997 % > 0.5%) |
| Asset Turnover: 132.2% > 50% (prev 135.2%; Δ -2.95% > 0%) |
| Interest Coverage Ratio: 7.37 > 6 (EBITDA TTM 1.62b / Interest Expense TTM 98.0m) |
Altman Z'' 2.58
| A: 0.09 (Total Current Assets 7.38b - Total Current Liabilities 5.89b) / Total Assets 17.06b |
| B: 0.38 (Retained Earnings 6.43b / Total Assets 17.06b) |
| C: 0.04 (EBIT TTM 722.0m / Avg Total Assets 17.18b) |
| D: 0.47 (Book Value of Equity 5.99b / Total Liabilities 12.74b) |
| Altman-Z'' Score: 2.58 = A |
Beneish M -3.29
| DSRI: 0.75 (Receivables 187.0m/258.0m, Revenue 22.71b/23.37b) |
| GMI: 1.01 (GM 40.38% / 40.86%) |
| AQI: 1.04 (AQ_t 0.15 / AQ_t-1 0.15) |
| SGI: 0.97 (Revenue 22.71b / 23.37b) |
| TATA: -0.06 (NI 478.0m - CFO 1.55b) / TA 17.06b) |
| Beneish M-Score: -3.29 (Cap -4..+1) = AA |
What is the price of M shares?
As of March 07, 2026, the stock is trading at USD 18.27 with a total of 10,215,307 shares traded.
Over the past week, the price has changed by -7.63%, over one month by -19.52%, over three months by -16.82% and over the past year by +44.88%.
Over the past week, the price has changed by -7.63%, over one month by -19.52%, over three months by -16.82% and over the past year by +44.88%.
Is M a buy, sell or hold?
Macy’s has received a consensus analysts rating of 3.15.
Therefor, it is recommend to hold M.
- StrongBuy: 2
- Buy: 0
- Hold: 10
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the M price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21.8 | 19.3% |
| Analysts Target Price | 21.8 | 19.3% |
M Fundamental Data Overview March 05, 2026
P/E Trailing = 10.7529
P/E Forward = 10.4275
P/S = 0.214
P/B = 1.1556
P/EG = 2.0057
Revenue TTM = 22.71b USD
EBIT TTM = 722.0m USD
EBITDA TTM = 1.62b USD
Long Term Debt = 2.43b USD (from longTermDebt, last quarter)
Short Term Debt = 6.00m USD (from shortTermDebt, last fiscal year)
Debt = 5.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.80b USD (from netDebt column, last quarter)
Enterprise Value = 9.66b USD (4.86b + Debt 5.24b - CCE 447.0m)
Interest Coverage Ratio = 7.37 (Ebit TTM 722.0m / Interest Expense TTM 98.0m)
EV/FCF = 8.88x (Enterprise Value 9.66b / FCF TTM 1.09b)
FCF Yield = 11.26% (FCF TTM 1.09b / Enterprise Value 9.66b)
FCF Margin = 4.79% (FCF TTM 1.09b / Revenue TTM 22.71b)
Net Margin = 2.10% (Net Income TTM 478.0m / Revenue TTM 22.71b)
Gross Margin = 40.38% ((Revenue TTM 22.71b - Cost of Revenue TTM 13.54b) / Revenue TTM)
Gross Margin QoQ = 41.89% (prev 41.99%)
Tobins Q-Ratio = 0.57 (Enterprise Value 9.66b / Total Assets 17.06b)
Interest Expense / Debt = 0.48% (Interest Expense 25.0m / Debt 5.24b)
Taxrate = 23.72% (181.0m / 763.0m)
NOPAT = 550.7m (EBIT 722.0m * (1 - 23.72%))
Current Ratio = 1.25 (Total Current Assets 7.38b / Total Current Liabilities 5.89b)
Debt / Equity = 1.21 (Debt 5.24b / totalStockholderEquity, last quarter 4.33b)
Debt / EBITDA = 2.96 (Net Debt 4.80b / EBITDA 1.62b)
Debt / FCF = 4.41 (Net Debt 4.80b / FCF TTM 1.09b)
Total Stockholder Equity = 4.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.78% (Net Income 478.0m / Total Assets 17.06b)
RoE = 10.75% (Net Income TTM 478.0m / Total Stockholder Equity 4.45b)
RoCE = 10.50% (EBIT 722.0m / Capital Employed (Equity 4.45b + L.T.Debt 2.43b))
RoIC = 7.76% (NOPAT 550.7m / Invested Capital 7.10b)
WACC = 5.17% (E(4.86b)/V(10.10b) * Re(10.35%) + D(5.24b)/V(10.10b) * Rd(0.48%) * (1-Tc(0.24)))
Discount Rate = 10.35% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.54%
[DCF] Terminal Value 86.28% ; FCFF base≈741.8m ; Y1≈737.6m ; Y5≈772.1m
[DCF] Fair Price = 68.64 (EV 23.05b - Net Debt 4.80b = Equity 18.25b / Shares 265.9m; r=5.90% [WACC]; 5y FCF grow -1.25% → 2.90% )
EPS Correlation: -45.04 | EPS CAGR: -58.49% | SUE: -4.0 | # QB: 0
Revenue Correlation: -39.42 | Revenue CAGR: -14.73% | SUE: 1.49 | # QB: 4
EPS next Quarter (2026-04-30): EPS=0.17 | Chg7d=+0.003 | Chg30d=+0.004 | Revisions Net=+2 | Analysts=9
EPS next Year (2027-01-31): EPS=2.19 | Chg7d=-0.042 | Chg30d=-0.026 | Revisions Net=+1 | Growth EPS=-0.5% | Growth Revenue=-3.2%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.1% (Discount Rate 10.3% - Earnings Yield 9.3%)
[Growth] Growth Spread = -5.6% (Analyst -4.5% - Implied 1.1%)
P/E Forward = 10.4275
P/S = 0.214
P/B = 1.1556
P/EG = 2.0057
Revenue TTM = 22.71b USD
EBIT TTM = 722.0m USD
EBITDA TTM = 1.62b USD
Long Term Debt = 2.43b USD (from longTermDebt, last quarter)
Short Term Debt = 6.00m USD (from shortTermDebt, last fiscal year)
Debt = 5.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.80b USD (from netDebt column, last quarter)
Enterprise Value = 9.66b USD (4.86b + Debt 5.24b - CCE 447.0m)
Interest Coverage Ratio = 7.37 (Ebit TTM 722.0m / Interest Expense TTM 98.0m)
EV/FCF = 8.88x (Enterprise Value 9.66b / FCF TTM 1.09b)
FCF Yield = 11.26% (FCF TTM 1.09b / Enterprise Value 9.66b)
FCF Margin = 4.79% (FCF TTM 1.09b / Revenue TTM 22.71b)
Net Margin = 2.10% (Net Income TTM 478.0m / Revenue TTM 22.71b)
Gross Margin = 40.38% ((Revenue TTM 22.71b - Cost of Revenue TTM 13.54b) / Revenue TTM)
Gross Margin QoQ = 41.89% (prev 41.99%)
Tobins Q-Ratio = 0.57 (Enterprise Value 9.66b / Total Assets 17.06b)
Interest Expense / Debt = 0.48% (Interest Expense 25.0m / Debt 5.24b)
Taxrate = 23.72% (181.0m / 763.0m)
NOPAT = 550.7m (EBIT 722.0m * (1 - 23.72%))
Current Ratio = 1.25 (Total Current Assets 7.38b / Total Current Liabilities 5.89b)
Debt / Equity = 1.21 (Debt 5.24b / totalStockholderEquity, last quarter 4.33b)
Debt / EBITDA = 2.96 (Net Debt 4.80b / EBITDA 1.62b)
Debt / FCF = 4.41 (Net Debt 4.80b / FCF TTM 1.09b)
Total Stockholder Equity = 4.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.78% (Net Income 478.0m / Total Assets 17.06b)
RoE = 10.75% (Net Income TTM 478.0m / Total Stockholder Equity 4.45b)
RoCE = 10.50% (EBIT 722.0m / Capital Employed (Equity 4.45b + L.T.Debt 2.43b))
RoIC = 7.76% (NOPAT 550.7m / Invested Capital 7.10b)
WACC = 5.17% (E(4.86b)/V(10.10b) * Re(10.35%) + D(5.24b)/V(10.10b) * Rd(0.48%) * (1-Tc(0.24)))
Discount Rate = 10.35% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.54%
[DCF] Terminal Value 86.28% ; FCFF base≈741.8m ; Y1≈737.6m ; Y5≈772.1m
[DCF] Fair Price = 68.64 (EV 23.05b - Net Debt 4.80b = Equity 18.25b / Shares 265.9m; r=5.90% [WACC]; 5y FCF grow -1.25% → 2.90% )
EPS Correlation: -45.04 | EPS CAGR: -58.49% | SUE: -4.0 | # QB: 0
Revenue Correlation: -39.42 | Revenue CAGR: -14.73% | SUE: 1.49 | # QB: 4
EPS next Quarter (2026-04-30): EPS=0.17 | Chg7d=+0.003 | Chg30d=+0.004 | Revisions Net=+2 | Analysts=9
EPS next Year (2027-01-31): EPS=2.19 | Chg7d=-0.042 | Chg30d=-0.026 | Revisions Net=+1 | Growth EPS=-0.5% | Growth Revenue=-3.2%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.1% (Discount Rate 10.3% - Earnings Yield 9.3%)
[Growth] Growth Spread = -5.6% (Analyst -4.5% - Implied 1.1%)